NCT06287593 2024-04-24
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
Zhejiang University
Phase NA Not yet recruiting
Clinical Trials
3 trialsNCT03749213 2018-11-21
Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage â…¢A-N2 Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT03349203 2018-07-18
Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown